![](/images/graphics-bg.png)
Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients
المؤلفون المشاركون
Sun, Wei
Wang, Chenqiong
Miao, Ye
Wu, Xuefen
Huang, Yishu
Sun, Mengchen
Zhu, Yingzi
Zheng, Fang
Dong, Lingli
المصدر
Journal of Immunology Research
العدد
المجلد 2016، العدد 2016 (31 ديسمبر/كانون الأول 2016)، ص ص. 1-8، 8ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2016-10-05
دولة النشر
مصر
عدد الصفحات
8
التخصصات الرئيسية
الملخص EN
Objective.
High mobility group box 1 (HMGB1) is a late inflammatory factor participating in the pathogenesis of various autoimmune and inflammatory diseases.
In the current study, we analyzed the association between serum levels of HMGB1 and clinical features of AS patients before and during treatment.
Methods.
Serum HMGB1 was detected in 147 AS patients and 61 healthy controls using ELISA.
We evaluated the association between HMGB1 and extra-articular manifestations as well as disease severity indices.
Among these AS patients, 41 patients received close follow-up at 1, 3, and 6 months after treatment.
This group comprised 25 patients treated with anti-TNF-α biologics and 16 patients receiving oral NSAIDs plus sulfasalazine.
Results.
The serum HMGB1 of AS patients was significantly higher than in healthy controls and positively correlated with BASDAI, BASFI, ASDAS-ESR, ASDAS-CRP, ESR, and CRP, but not with HLA-B27, anterior uveitis, and recurrent diarrhea.
There was no significant difference between patients with radiographic damage of hip joints and those without.
We observed that serum HMGB1 paralleled disease activity after treatment.
Conclusion.
Serum level of HMGB1 is higher in AS patients, and to some extent, HMGB1 can reflect the activity of AS and be used as a laboratory indicator to reflect the therapeutic response.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Wang, Chenqiong& Miao, Ye& Wu, Xuefen& Huang, Yishu& Sun, Mengchen& Zhu, Yingzi…[et al.]. 2016. Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients. Journal of Immunology Research،Vol. 2016, no. 2016, pp.1-8.
https://search.emarefa.net/detail/BIM-1108849
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Wang, Chenqiong…[et al.]. Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients. Journal of Immunology Research No. 2016 (2016), pp.1-8.
https://search.emarefa.net/detail/BIM-1108849
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Wang, Chenqiong& Miao, Ye& Wu, Xuefen& Huang, Yishu& Sun, Mengchen& Zhu, Yingzi…[et al.]. Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients. Journal of Immunology Research. 2016. Vol. 2016, no. 2016, pp.1-8.
https://search.emarefa.net/detail/BIM-1108849
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1108849
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)